Fairvalue-Calculator Fairvalue-Calculator
EN DE

Xtant Medical Holdings (XTNT) Fair Value & Analysis

Healthcare · US · Market cap $61.5M

Price$0.4300
Fair Value$0.7800
Upside+81.4%
Quality95/100
Evidence: High Range $0.5800 – $0.9800

Fair value as of: Jun 25, 2026

Analysis

Xtant Medical Holdings (XTNT) currently trades at $0.4300, while our model-based Fair Value estimate is $0.7800 — implying the stock looks roughly 81.4% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate lig…

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -9% Boston Scientific Corporation (B1SX34) -83% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Xtant Medical Holdings (XTNT) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $0.7800 versus a price of $0.4300 — about +81% (undervalued). Model-based estimate, not financial advice.
What is the fair value of XTNT?
Our 21-model fair value for Xtant Medical Holdings is $0.7800 (as of Jun 25, 2026), built from audited fundamentals. The current price is $0.4300.
What is the quality score of XTNT?
Xtant Medical Holdings has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.